Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
6.35
-0.48 (-7.03%)
At close: Jun 27, 2025, 4:00 PM
6.75
+0.40 (6.30%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Emergent BioSolutions Employees
Emergent BioSolutions had 900 employees as of December 31, 2024. The number of employees decreased by 700 or -43.75% compared to the previous year.
Employees
900
Change (1Y)
-700
Growth (1Y)
-43.75%
Revenue / Employee
$1,072,667
Profits / Employee
-$146,222
Market Cap
344.66M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
EBS News
- 5 days ago - Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply - GlobeNewsWire
- 8 days ago - Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful - Seeking Alpha
- 8 days ago - Emergent BioSolutions Announces Addition to Russell 3000® Index - GlobeNewsWire
- 23 days ago - Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies - GlobeNewsWire
- 6 weeks ago - Emergent BioSolutions to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Emergent BioSolutions Inc. (EBS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Emergent BioSolutions Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health - GlobeNewsWire